Cargando…

Exploring the microbiome of oral epithelial dysplasia as a predictor of malignant progression

A growing body of research associates the oral microbiome and oral cancer. Well-characterized clinical samples with outcome data are required to establish relevant associations between the microbiota and disease. The objective of this study was to characterize the community variations and the functi...

Descripción completa

Detalles Bibliográficos
Autores principales: Wright, Robyn J., Pewarchuk, Michelle E., Marshall, Erin A., Murrary, Benjamin, Rosin, Miriam P., Laronde, Denise M., Zhang, Lewei, Lam, Wan L., Langille, Morgan G. I., Rock, Leigha D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10080811/
https://www.ncbi.nlm.nih.gov/pubmed/37024828
http://dx.doi.org/10.1186/s12903-023-02911-5
_version_ 1785020991959728128
author Wright, Robyn J.
Pewarchuk, Michelle E.
Marshall, Erin A.
Murrary, Benjamin
Rosin, Miriam P.
Laronde, Denise M.
Zhang, Lewei
Lam, Wan L.
Langille, Morgan G. I.
Rock, Leigha D.
author_facet Wright, Robyn J.
Pewarchuk, Michelle E.
Marshall, Erin A.
Murrary, Benjamin
Rosin, Miriam P.
Laronde, Denise M.
Zhang, Lewei
Lam, Wan L.
Langille, Morgan G. I.
Rock, Leigha D.
author_sort Wright, Robyn J.
collection PubMed
description A growing body of research associates the oral microbiome and oral cancer. Well-characterized clinical samples with outcome data are required to establish relevant associations between the microbiota and disease. The objective of this study was to characterize the community variations and the functional implications of the microbiome in low-grade oral epithelial dysplasia (OED) using 16S rRNA gene sequencing from annotated archival swabs in progressing (P) and non-progressing (NP) OED. We characterised the microbial community in 90 OED samples — 30 swabs from low-grade OED that progressed to cancer (cases) and 60 swabs from low-grade OED that did not progress after a minimum of 5 years of follow up (matched control subjects). There were small but significant differences between P and NP samples in terms of alpha diversity as well as beta diversity in conjunction with other clinical factors such as age and smoking status for both taxa and functional predictions. Across all samples, the most abundant genus was Streptococcus, followed by Haemophilus, Rothia, and Neisseria. Taxa and predicted functions were identified that were significantly differentially abundant with progression status (all Ps and NPs), when samples were grouped broadly by the number of years between sampling and progression or in specific time to progression for Ps only. However, these differentially abundant features were typically present only at low abundances. For example, Campylobacter was present in slightly higher abundance in Ps (1.72%) than NPs (1.41%) and this difference was significant when Ps were grouped by time to progression. Furthermore, several of the significantly differentially abundant functions were linked to the Campylobacteraceae family in Ps and may justify further investigation. Larger cohort studies to further explore the microbiome as a potential biomarker of risk in OED are warranted. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12903-023-02911-5.
format Online
Article
Text
id pubmed-10080811
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-100808112023-04-08 Exploring the microbiome of oral epithelial dysplasia as a predictor of malignant progression Wright, Robyn J. Pewarchuk, Michelle E. Marshall, Erin A. Murrary, Benjamin Rosin, Miriam P. Laronde, Denise M. Zhang, Lewei Lam, Wan L. Langille, Morgan G. I. Rock, Leigha D. BMC Oral Health Research A growing body of research associates the oral microbiome and oral cancer. Well-characterized clinical samples with outcome data are required to establish relevant associations between the microbiota and disease. The objective of this study was to characterize the community variations and the functional implications of the microbiome in low-grade oral epithelial dysplasia (OED) using 16S rRNA gene sequencing from annotated archival swabs in progressing (P) and non-progressing (NP) OED. We characterised the microbial community in 90 OED samples — 30 swabs from low-grade OED that progressed to cancer (cases) and 60 swabs from low-grade OED that did not progress after a minimum of 5 years of follow up (matched control subjects). There were small but significant differences between P and NP samples in terms of alpha diversity as well as beta diversity in conjunction with other clinical factors such as age and smoking status for both taxa and functional predictions. Across all samples, the most abundant genus was Streptococcus, followed by Haemophilus, Rothia, and Neisseria. Taxa and predicted functions were identified that were significantly differentially abundant with progression status (all Ps and NPs), when samples were grouped broadly by the number of years between sampling and progression or in specific time to progression for Ps only. However, these differentially abundant features were typically present only at low abundances. For example, Campylobacter was present in slightly higher abundance in Ps (1.72%) than NPs (1.41%) and this difference was significant when Ps were grouped by time to progression. Furthermore, several of the significantly differentially abundant functions were linked to the Campylobacteraceae family in Ps and may justify further investigation. Larger cohort studies to further explore the microbiome as a potential biomarker of risk in OED are warranted. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12903-023-02911-5. BioMed Central 2023-04-06 /pmc/articles/PMC10080811/ /pubmed/37024828 http://dx.doi.org/10.1186/s12903-023-02911-5 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Wright, Robyn J.
Pewarchuk, Michelle E.
Marshall, Erin A.
Murrary, Benjamin
Rosin, Miriam P.
Laronde, Denise M.
Zhang, Lewei
Lam, Wan L.
Langille, Morgan G. I.
Rock, Leigha D.
Exploring the microbiome of oral epithelial dysplasia as a predictor of malignant progression
title Exploring the microbiome of oral epithelial dysplasia as a predictor of malignant progression
title_full Exploring the microbiome of oral epithelial dysplasia as a predictor of malignant progression
title_fullStr Exploring the microbiome of oral epithelial dysplasia as a predictor of malignant progression
title_full_unstemmed Exploring the microbiome of oral epithelial dysplasia as a predictor of malignant progression
title_short Exploring the microbiome of oral epithelial dysplasia as a predictor of malignant progression
title_sort exploring the microbiome of oral epithelial dysplasia as a predictor of malignant progression
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10080811/
https://www.ncbi.nlm.nih.gov/pubmed/37024828
http://dx.doi.org/10.1186/s12903-023-02911-5
work_keys_str_mv AT wrightrobynj exploringthemicrobiomeoforalepithelialdysplasiaasapredictorofmalignantprogression
AT pewarchukmichellee exploringthemicrobiomeoforalepithelialdysplasiaasapredictorofmalignantprogression
AT marshallerina exploringthemicrobiomeoforalepithelialdysplasiaasapredictorofmalignantprogression
AT murrarybenjamin exploringthemicrobiomeoforalepithelialdysplasiaasapredictorofmalignantprogression
AT rosinmiriamp exploringthemicrobiomeoforalepithelialdysplasiaasapredictorofmalignantprogression
AT larondedenisem exploringthemicrobiomeoforalepithelialdysplasiaasapredictorofmalignantprogression
AT zhanglewei exploringthemicrobiomeoforalepithelialdysplasiaasapredictorofmalignantprogression
AT lamwanl exploringthemicrobiomeoforalepithelialdysplasiaasapredictorofmalignantprogression
AT langillemorgangi exploringthemicrobiomeoforalepithelialdysplasiaasapredictorofmalignantprogression
AT rockleighad exploringthemicrobiomeoforalepithelialdysplasiaasapredictorofmalignantprogression